WTW

Willis Towers Watson is expected to report Q3 2026 earnings of $3.60 per share (up 17.3% YoY) and revenues of $2.48 billion (up 8.3% YoY) on October 29. However, with a Zacks Rank of #4 and a modest Earnings ESP of +0.52%, the stock is not considered a compelling earnings-beat candidate despite analysts' recent bullish revisions.

Willis Towers Watson (WTW) reported solid Q2 organic growth across all segments, with R&B at 7%, HWC at 4%, and Insurance Consulting and Technology at 6%. The company's Propel AI initiative targets $400 million in annualized savings by 2028, supporting its 30% operating margin goal.

Trading at a discount to industry peers with a forward P/E of 13.47X, WTW shows strong fundamentals including 66% year-over-year free cash flow growth and planned $1 billion in share repurchases. Analysts project 15.9% EPS growth for 2026 with an average price target suggesting 25.7% upside.

Willis Towers Watson (WTW) is expanding AI-driven insurance technology capabilities through platforms like RiskIQ Nexus and Radar AI Assistant to improve risk management and underwriting. The company's Propel AI program targets $400 million in annualized savings by 2028, with $350 million retained after reinvestment.

WTW aims for a 30% adjusted operating margin by 2028, though implementation costs and adoption risks remain concerns. The stock trades at a lower P/E multiple than peers and carries a Zacks Rank #3 (Hold) rating.

Willis Towers Watson (WTW) achieved 5% organic revenue growth in Q2 2026, driven by its Risk & Broking segment (7% growth) and specialization strategy. The company maintains mid-single-digit growth guidance for 2026, though sustaining this pace depends on continued new business wins and offsetting softer insurance pricing. Peers Brown & Brown faced headwinds with declining organic growth, while Arthur J. Gallagher demonstrated stronger positioning with 6% organic growth expectations.

Neptune Insurance (NP) is expected to report Q3 2026 earnings on October 20 with projected EPS growth of 45.5% year-over-year and revenue growth of 23.9%. The company is anticipated to benefit from increased policies in force (323,300 expected), higher fee income, and improved workforce productivity.

However, rising commissions and administrative expenses may offset some gains. The stock has a Zacks Rank #2 (Buy) with a positive Earnings ESP of +1.82%, suggesting a likely earnings beat.

Marsh & McLennan (MRSH) is expected to report Q3 2026 earnings on October 15 with EPS estimated at $1.96 on $6.63 billion in revenues, representing 6% year-over-year growth. The company has beaten consensus estimates in the last four quarters and is predicted to beat again, supported by 4.1% growth in Risk and Insurance Services revenues and 5.6% growth in adjusted operating income. However, rising operating expenses (up ~3%) and a 27% decline in interest income may partially offset gains.